Abstract.
The effect of growth hormone (GH) on subclinical disease activity in a 15-year-old boy with previously quiescent lupus nephritis and chronic renal failure is described. Institution of supraphysiological doses of GH resulted in a rise in erythrocyte sedimentation rate, decrease in serum complement, rise in anti-DNA antibody titers, and increase in T-cell activation markers, all of which improved following cessation of GH treatment.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received April 3, 1997; received in revised form September 2, 1997; accepted September 3, 1997
Rights and permissions
About this article
Cite this article
Yap, HK., Loke, KY., Murugasu, B. et al. Subclinical activation of lupus nephritis by recombinant human growth hormone. Pediatr Nephrol 12, 133–135 (1998). https://doi.org/10.1007/s004670050421
Issue Date:
DOI: https://doi.org/10.1007/s004670050421